Private health insurer HBF has announced it will partner with two of Western Australia's medical research organisations to fund projects with significant potential, including one that aims to assist patients with melanoma who do not respond to immunotherapy. …
Insurer backs project researching why patients don't respond to immunotherapy
December 15, 2022 Other Health
Latest Video
New Stories
-
Argenica validates optimal dose of ARG-007 in independent preclinical stroke study
November 25, 2025 - - Australian Biotech -
NSW Premier opens Australia’s first large-scale health translation hub at UNSW
November 24, 2025 - - Latest News -
Cynata completes final patient visits in pivotal Phase 3 osteoarthritis trial
November 24, 2025 - - Australian Biotech -
New review recommends a balanced and measured approach to adopting AI in clinical practice
November 24, 2025 - - BioPharma -
Sanofi becomes first tenant of ENTRI, marking major step for Queensland’s translational research ambitions
November 24, 2025 - - Latest News -
Moderna names CSIRO scientist Dr Anne Klein as 2025 Australian Fellow
November 24, 2025 - - Australian Biotech -
New national report warns of deepening ovarian cancer burden and calls for urgent action
November 24, 2025 - - Latest News